Tag: Merger

Displaying 81 - 100 of 537 results.

The Commission charged that Schering-Plough’s proposed $14.4 billion acquisition of Organon Biosciences N.V. threatened to substantially reduce competition in the U.S. market for three popular vaccines used to treat poultry, a staple in American food markets. The November 2007 order...
In the case of Inova Prince William (0610166) the Commission authorized both an Administrative Complaint and a PI to challenge the proposed merger of Inova Health System Foundation’s and Prince William Health System (PWHS) pending a full administrative trial on the merits. The...
The Commission challenged McCormick & Company’s $605 million acquisition of Lawry’s and Adolph’s brands of seasoned salt products from Unilever N.V., alleging that the transaction would be detrimental to competition in the highly concentrated U.S. market for seasoned salts....
The Commission charged that Sun Pharmaceutical Industries Ltd’s proposed acquisition of Taro Pharmaceuticals Industries, Ltd would substantially reduce competition, likely resulting in higher prices for three distinct generic formulations of the anticonvulsant drug carbamazepine,...
Service Corporation International (SCI), the nation’s largest provider of funeral and cemetery services, has settled Commission charges that its proposed acquisition of Keystone North America Inc. (Keystone), the fifth-largest funeral and cemetery services provider in North America,...
Agilent Technologies, Inc. and Varian, Inc., two leading global suppliers of high-performance scientific measurement instruments, have agreed to sell three of their product lines in order to proceed with their proposed $1.5 billion merger. According to the FTC’s complaint, Agilent’s...
To settle Federal Trade Commission charges that its proposed acquisition of Alcon, Inc., would be anticompetitive, Novartis AG agreed to sell an injectable eye care drug used in cataract surgery. Novartis and Alcon are the only two U.S. providers of the class of drugs known as...
As part of a settlement, The Coca-Cola Company agreed to restrict its access to confidential competitive business information of rival Dr Pepper Snapple Group as a condition for completing Coca-Cola’s proposed $12.3 billion acquisition of its largest North American bottler, which...
The Commission required Hikma Pharmaceuticals PLC (Hikma) to divest two generic injectable pharmaceuticals – phenytoin and promethazine – as part of a settlement allowing it to acquire certain assets from Baxter Healthcare Corporation, Inc. (Baxter). Hikma proposes to acquire Baxter’...
On 7/26/2011, the Commission required generic drug manufacturers Perrigo Company and Paddock Laboratories, Inc. to sell six generic drugs under a proposed settlement resolving charges that Perrigo’s proposed $540 million acquisition of Paddock would be anticompetitive. The proposed...
On 10/7/2011, the FTC required Teva Pharmaceutical Industries Ltd. to sell the rights and assets related to a generic cancer pain drug and a generic muscle relaxant, as a condition of its proposed $6.8 billion acquisition of rival drug firm Cephalon, Inc. In addition, the proposed...
On 10/28/2011, the FTC reached a settlement with Healthcare Technology Holdings, Inc., the parent company of market research firm IMS Health Inc., according to which IMS has agreed to sell two product lines of rival SDI Health LLC, as a condition of allowing it to proceed with its...
On 6/15/2012, the FTC required Koninklijke Ahold N.V., the parent company of Giant Food Stores, LLC, to sell a supermarket outside of Philadelphia, Pennsylvania, to settle charges that its proposed acquisition of the Genuardi's supermarket chain from Safeway Inc. otherwise would be...
On 11/15/2012, the FTC required Hertz Global Holdings, Inc. (Hertz) to sell its Advantage Rent A Car (Advantage) business, as well as the rights to operate 29 Dollar Thrifty Automotive Group, Inc. (Dollar Thrifty) on-airport locations around the country, under a proposed settlement...
This content is also available as a pdf.
The Federal Trade Commission plans to hold a one-day public workshop to examine developments in the health care sector relating to “clinical integration” among health care providers. Clinical integration is a term used to describe certain types of collaborations among otherwise...
For nearly two decades, the Federal Trade Commission and the Antitrust Division of the Department of Justice have actively promoted market competition around the world by providing technical assistance, initially with funding from the U.S. Agency for International Development and now...
This conference, sponsored by the FTC Bureau of Economics, looked at antitrust analysis of the grocery industry including both historical analysis and analysis of current methods. The roundtable included both paper presentations and panel sessions. The paper presentations included...
The FTC hosted a public conference to examine two recent studies focusing on the price effects of mergers and concentration in the United States petroleum industry. The conference brought together a group of independent economic experts to evaluate two studies examining price effects...

Pages